Business Context and Reporting Period
This Form 10-K covers the fiscal year ended December 31, 1995, for Philip Morris Companies Inc. (Note: The request metadata listed "Altria Group," but the filing text identifies the registrant as Philip Morris Companies Inc., the predecessor to Altria). The Company is a holding company and the largest consumer packaged goods company in the world, with principal subsidiaries including Philip Morris Incorporated (tobacco), Kraft Foods, Inc. (food), and Miller Brewing Company (beer).
Key Financial Metrics and Operational Data
Specific consolidated revenue, net income, and cash flow figures are incorporated by reference to the 1995 Annual Report and are not explicitly stated in the text of this filing. However, the following operational and segment data are provided:
- Tobacco Segment: Contributed approximately 65% of total operating profit in 1995 (up from 62% in 1994).
- Domestic (PM Inc.): Shipments totaled 221.8 billion units (up 1.1% from 1994), representing a 46.1% U.S. market share. Marlboro shipments were 144.9 billion units (30.1% U.S. share).
- International: Shipments grew 10.7% to approximately 593.2 billion units. Global market share (excluding U.S.) was approximately 12%.
- Food Segment (Kraft): Contributed approximately 29% of total operating profit. Kraft is the largest packaged food company in North America.
- Beer Segment (Miller): Contributed approximately 4% of total operating profit. Total shipment volume decreased 0.5% to 45,006 thousand barrels, maintaining a 22.7% industry share.
- Financial Services: Contributed approximately 2% of total operating profit. Total assets for Philip Morris Capital Corporation increased to $5.6 billion.
- Capital Allocation: The Company is repurchasing shares at an annualized rate of $2.6 billion under a $6 billion program.
- Employees: Approximately 151,000 worldwide as of December 31, 1995.
Material Changes Versus Prior Period
- Tobacco Profit Mix: Operating profit from tobacco products increased its share of total company profit from 62% in 1994 to 65% in 1995.
- Market Share Gains: PM Inc. increased its U.S. cigarette market share by 1.3 points to 46.1%. Marlboro's U.S. share increased by 2.0 points to 30.1%.
- International Growth: Philip Morris International's unit shipments grew significantly (10.7%), outpacing the estimated 1% global industry growth.
- Segment Shifts: The domestic tobacco market continued to shift from discount to premium segments. Premium cigarettes accounted for 82.7% of PM Inc.'s volume in 1995 (up from 80.7% in 1994).
- Divestitures: Kraft sold its bakery businesses, North American margarine, and other non-core food businesses in 1995 to improve profit margins.
Outlook, Risks, and Contingencies
Regulatory and Legal Risks: The tobacco industry faces substantial risks from health concerns, litigation, and regulation.
- Litigation: As of December 31, 1995, there were 125 smoking and health cases pending in the U.S. against PM Inc. and the Company. Significant class action cases (e.g., Engle, Castano) are ongoing. The Company states it cannot estimate the range of loss but believes the ultimate outcome should not have a material adverse effect on its financial position.
- FDA Regulation: The FDA initiated a rulemaking proceeding asserting jurisdiction over nicotine as a "drug" and cigarettes as a "device." The Company is challenging this in court.
- Taxes: Excise taxes are increasing at federal and state levels, which historically have an adverse impact on sales volume.
- Environmental: The Company is involved in approximately 185 environmental matters with potential remediation costs, though these are not expected to be material.
Management Commentary: Management emphasizes the shift to premium products as a strategy to maintain profitability despite declining industry volumes. The Company is actively defending against litigation and regulatory challenges while continuing to invest in international capacity and product innovation.
Investor Verification Checklist
- Verify the specific consolidated revenue and net income figures in the 1995 Annual Report (incorporated by reference), as they are not detailed in this text.
- Monitor the status of the FDA rulemaking and related litigation regarding the regulation of nicotine and cigarettes.
- Track developments in the Engle and Castano class action lawsuits, as well as state Medicaid reimbursement actions.
- Review the impact of excise tax increases on future volume projections for the tobacco segment.
- Assess the progress of the $6 billion share repurchase program and its effect on earnings per share.